Bank Julius Baer & Co’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,500
Closed -$16K 816
2021
Q4
$16K Sell
2,500
-26,000
-91% -$178K ﹤0.01% 762
2021
Q3
$227K Sell
28,500
-60,953
-68% -$502K ﹤0.01% 530
2021
Q2
$670K Sell
89,453
-7,046
-7% -$49.2K ﹤0.01% 409
2021
Q1
$584K Buy
96,499
+46,937
+95% +$361K ﹤0.01% 421
2020
Q4
$283K Sell
49,562
-16,436
-25% -$105K ﹤0.01% 520
2020
Q3
$439K Sell
65,998
-135,501
-67% -$1.21M ﹤0.01% 401
2020
Q2
$1.78M Sell
201,499
-41,260
-17% -$119K 0.02% 210
2020
Q1
$432K Buy
+242,759
New +$309K 0.01% 332

Other funds holding VXRT

Bank Julius Baer & Co's VXRT Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Vaxart (VXRT) in Q1 2022, closing a stake of 2,500 shares — an estimated $16K sold.

Bank Julius Baer & Co first reported a position in VXRT in Q1 2020 and held it in 8 quarters. The position peaked at $1.78M in Q2 2020. 148 funds tracked by Wall St. Rank hold VXRT as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Vaxart position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 2,500 Vaxart shares in Q1 2022, an estimated $16K.
  • Bank Julius Baer & Co first reported a position in Vaxart in Q1 2020 and held it in 8 quarters.
  • Bank Julius Baer & Co's Vaxart position peaked at $1.78M in Q2 2020.
  • 148 funds tracked by Wall St. Rank held Vaxart as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.